ALERT TO OLO PHARMACEUTICALS SHAREHOLDERS: APPLICANT REMINDS INVESTORS
NEW ORLEANS, Oct. 25, 2022 (GLOBE NEWSWIRE) — ClaimsFiler, a FREE shareholder information service, is reminding investors they have until November 28, 2022 Lead Plaintiff’s motions in a securities class action lawsuit against Olo Inc. OLOif you purchased the Company’s Shares between August 11, 2021 and August 11, 2022 inclusive (the “Class Period”). This lawsuit […]
ALERT TO OLO PHARMACEUTICALS SHAREHOLDERS: DAMAGES REMINDER
NEW ORLEANS, Oct. 25, 2022 (GLOBE NEWSWIRE) — ClaimsFiler, a FREE shareholder information service, is reminding investors they have until November 28, 2022 Lead plaintiff motions in a securities class action lawsuit against Olo Inc. (NYSE: OLO) if they purchased the Company’s stock between August 11, 2021 and August 11, 2022 inclusive (the “Class Period”). […]
CENTESSA PHARMACEUTICALS SHAREHOLDER WARNING: DAMAGES REMINDER
NEW ORLEANS, Oct. 25, 2022 (GLOBE NEWSWIRE) — ClaimsFiler, a FREE shareholder information service, is reminding investors they have until November 28, 2022 Lead plaintiff’s motions in a securities class action against Centessa Pharmaceuticals plc CNTAif they purchased or otherwise acquired the Company’s securities and/or purchased the Company’s American Depositary Shares (“ADSs”) between May 28, […]
CENTESSA PHARMACEUTICALS SHAREHOLDER WARNING: APPLICANTS
NEW ORLEANS, Oct. 25, 2022 (GLOBE NEWSWIRE) — ClaimsFiler, a FREE shareholder information service, is reminding investors they have until November 28, 2022 Lead Plaintiff motions to file in a securities class action lawsuit against Centessa Pharmaceuticals plc (NasdaqGS: CNTA) if they purchased or otherwise acquired the Company’s securities between May 28, 2021 and June […]
SHAREHOLDER OF CENTESSA PHARMACEUTICALS PLC (NASDAQ: CNTA).
Have you lost money investing in Centessa Pharmaceuticals? If yes, please visit us Class Action by Centessa Pharmaceuticals plc Shareholders or contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights. NEW YORK, Oct. 25, 2022 (GLOBE NEWSWIRE) — Bernstein Liebhard LLP, a nationally recognized investor rights law firm, is reminding investors of […]
CENTESSA PHARMACEUTICALS PLC (NASDAQ: CNTA) SHAREHOLDERS’ CLASS ACTION.
Have you lost money investing in Centessa Pharmaceuticals? If yes, please visit us Class Action by Centessa Pharmaceuticals plc Shareholders or contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights. NEW YORK, Oct. 25, 2022 (GLOBE NEWSWIRE) — Bernstein Liebhard LLP, a nationally recognized investor rights law firm, is reminding investors of […]
Centessa Pharmaceuticals plc Investors: please contact the
LOS ANGELES, Oct. 20, 2022 (GLOBE NEWSWIRE) — The law firm of Portnoy Centessa Pharmaceuticals plc (“Centessa” or the “Company”) (NASDAQ: CNTA) announces that it has filed a class action lawsuit on behalf of investors. Centessa investors who have lost money investing are encouraged to do so Contact Lesley Portnoy, Esq. Investors are encouraged to […]
Centessa Pharmaceuticals plc (CNTA) Class Action Notice: If you
SAN DIEGO, Oct. 19, 2022 (GLOBE NEWSWIRE) — The class: Law firm for shareholder rights Robbins LLP reminds investors that a shareholder has filed a class action lawsuit on behalf of all individuals and entities that have purchased Centessa Pharmaceuticals plc CNTA American Depository Shares (ADS) pursuant to the Company’s initial public offering on May […]
Centessa Pharmaceuticals plc (CNTA) Class Action Notice: If
SAN DIEGO, Oct. 19, 2022 (GLOBE NEWSWIRE) — The class: Law firm for shareholder rights Robbins LLP Reminds investors that a shareholder has filed a class action lawsuit on behalf of all persons and entities holding Centessa Pharmaceuticals plc’s (NASDAQ: CNTA) American Depository Shares (ADS) pursuant to the Company’s initial public offering of May 28, […]
This pharmaceutical company just received another psychedelics patent and kit
short drama psychedelics biotech company Small Pharma Inc. DMTTF received a USPTO patent protecting the Composition Matter of a group of deuterated DMT compoundswith expected exclusivity until April 2041. “We have done great progress this year advancing our research and development programs and securing important intellectual property to support and protect it,” he said Managing […]
CENTESSA PHARMACEUTICALS SHAREHOLDER WARNING BY FORMER LOUISIANA
NEW ORLEANS, Oct. 18, 2022 (GLOBE NEWSWIRE) — Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Louisiana Attorney General Charles C. Foti, Jr., remind investors that they have until November 28, 2022 Lead plaintiff’s motions in a securities class action against Centessa Pharmaceuticals plc CNTAif they purchased or otherwise acquired the Company’s securities […]
CENTESSA PHARMACEUTICALS SHAREHOLDER WARNING BY FORMER
NEW ORLEANS, Oct. 18, 2022 (GLOBE NEWSWIRE) — Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Louisiana Attorney General Charles C. Foti, Jr., remind investors that they have until November 28, 2022 Lead Plaintiff motions to file in a securities class action against Centessa Pharmaceuticals plc (NasdaqGS: CNTA) if they purchased or otherwise […]